glp-1 shortage canada news today A new survey suggests about 3 million Canadian adults are currently taking drugs like Ozempic or Mounjaro — and over 2 million more would like to. Nearly 60% of people taking CPHA: Canada Now Second-Largest GLP-1

The median age of the analysis cohort was 60 years (range: 23-85), 62 (50.4%) were women

MariTide, which Amgen said would be taken monthly or less frequently, also significantly reduced symptoms like nausea and vomiting as patients increased their dosage

People looking for virtual, ongoing provider support Women seeking medically guided weight loss Those priced out of traditional GLP-1 care Which treatments does the program include

It is also important to note that most of these studies focus on short-term effects that may not hold up with extended use

Many patients on these drugs also report a reduced thirst drive, meaning they don't drink enough water to replace what is lost

This is why compounded tirzepatide users often prefer gentler escalation schedules